OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine Tumors
Vincent Vandecaveye, Raphaëla C. Dresen, Elin Pauwels, et al.
Radiology Imaging Cancer (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 7
Vincent Vandecaveye, Raphaëla C. Dresen, Elin Pauwels, et al.
Radiology Imaging Cancer (2022) Vol. 4, Iss. 3
Open Access | Times Cited: 7
Showing 7 citing articles:
Imaging DNA damage response by γH2AX in vivo predicts treatment response to Lutetium-177 radioligand therapy and suggests senescence as a therapeutically desirable outcome
Edward O’Neill, Michael Mosley, Bart Cornelissen
Theranostics (2023) Vol. 13, Iss. 4, pp. 1302-1310
Open Access | Times Cited: 10
Edward O’Neill, Michael Mosley, Bart Cornelissen
Theranostics (2023) Vol. 13, Iss. 4, pp. 1302-1310
Open Access | Times Cited: 10
Challenges in developing response evaluation criteria for peptide receptor radionuclide therapy: A consensus report from the European Neuroendocrine Tumor Society Advisory Board Meeting 2022 and the ENETS Theranostics Task Force
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 3
Vikas Prasad, Anna Koumarianou, Timm Denecke, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 3
Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review
Giulia Poletto, Diego Cecchin, Stefania Sperti, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 11, pp. 5516-5530
Open Access | Times Cited: 11
Giulia Poletto, Diego Cecchin, Stefania Sperti, et al.
Current Issues in Molecular Biology (2022) Vol. 44, Iss. 11, pp. 5516-5530
Open Access | Times Cited: 11
Utility of clinical and MR imaging parameters for prediction and monitoring of response to capecitabine and temozolomide (CAPTEM) therapy in patients with liver metastases of neuroendocrine tumors
Maria Ingenerf, Christoph J. Auernhammer, Roberto Lorbeer, et al.
Radiology and Oncology (2024) Vol. 58, Iss. 2, pp. 196-205
Open Access | Times Cited: 1
Maria Ingenerf, Christoph J. Auernhammer, Roberto Lorbeer, et al.
Radiology and Oncology (2024) Vol. 58, Iss. 2, pp. 196-205
Open Access | Times Cited: 1
Assessment of response to PRRT including anatomical and molecular imaging as well as novel biomarkers
Grace Kong, Geertje Noë, Cherie Chiang, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 1
Grace Kong, Geertje Noë, Cherie Chiang, et al.
Journal of Neuroendocrinology (2024)
Open Access | Times Cited: 1
Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters
Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2618-2618
Open Access | Times Cited: 4
Maria Ingenerf, Sophia Kiesl, Michael Winkelmann, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2618-2618
Open Access | Times Cited: 4
Intra-individual qualitative and quantitative comparison of [68Ga]Ga-DOTATATE PET/CT and PET/MRI
Géraldine Lens, Niloefar Ahmadi Bidakhvidi, Vincent Vandecaveye, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access
Géraldine Lens, Niloefar Ahmadi Bidakhvidi, Vincent Vandecaveye, et al.
Therapeutic Advances in Medical Oncology (2023) Vol. 15
Open Access
